Status:
UNKNOWN
Bringing Parkinson Care Back Home
Lead Sponsor:
Radboud University Medical Center
Conditions:
Parkinson Disease
Eligibility:
All Genders
18-100 years
Brief Summary
SUMMARY Rationale: For persons with Parkinson's disease (PD), medical decisions are based almost exclusively on periodic in-clinic evaluations by a neurologist or a nurse. For a variety of reasons, s...
Eligibility Criteria
Inclusion
- Subjects must confirm that they have been diagnosed with Parkinson's Disease by a neurologist (self-reported)
- Age 18 or older
- At least 1 fall incident in the previous 6 months. A fall is defined as any unexpected event that caused the person to unintentionally land on any lower surface (object, floor, or ground), regardless of any sustained injury (self-reported)
- Able and willing to provide written informed consent in accordance with Good Clinical Practice, and national and local regulation
- Fluent in Dutch
Exclusion
- The patients receives advanced therapy for their Parkinson's disease (deep brain stimulation, duodopa pump, apomorphine pump);
- The patients shows cognitive of psychiatric impairments that may hinder successful completion of the study protocol (as judged by the researcher running the recruitment).
Key Trial Info
Start Date :
March 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2023
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04288583
Start Date
March 1 2021
End Date
June 30 2023
Last Update
April 4 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Radboud university medical center
Nijmegen, Netherlands